WINDTREE THERAPEUTICS INC /DE/: 10-Q filed 2015-11-05
What WINDTREE THERAPEUTICS INC /DE/ reported in its quarterly report filed 2015-11-05 (fiscal Q3 2015): 29 published measures, 80 facts as tagged in accession 0001140361-15-039840.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-11-05
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001140361-15-039840 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All WINDTREE THERAPEUTICS INC /DE/ filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 52,732,000 | USD | |
| At 2014-12-31 | 47,499,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 34,842,000 | USD | |
| At 2014-12-31 | 28,300,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 17,890,000 | USD | |
| At 2014-12-31 | 19,199,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 46,308,000 | USD | |
| At 2014-12-31 | 44,711,000 | USD | |
| At 2014-09-30 | 54,915,000 | USD | |
| At 2013-12-31 | 86,283,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -21,556,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -45,061,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -11,324,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -33,423,000 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 508,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 679,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -569,069,000 | USD | |
| At 2014-12-31 | -524,008,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 105,696,000 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 92,420,000 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 85,209,000 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 85,001,000 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 105,696,000 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 92,420,000 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 85,209,000 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 86,121,000 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -0.2 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -0.49 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | -0.13 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | -0.39 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -0.2 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | -0.49 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | -0.13 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | -0.41 | USD/shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,186,000 | USD | |
| At 2014-12-31 | 1,637,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -8,443,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -30,053,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -10,327,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -32,032,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 48,727,000 | USD | |
| At 2014-12-31 | 45,559,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 9,786,000 | USD | |
| At 2014-12-31 | 7,829,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 2,457,000 | USD | |
| At 2014-12-31 | 350,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 8,509,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 30,385,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 10,854,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 33,683,000 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 0 | USD | |
| At 2014-12-31 | 27,000 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 2,057,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 8,793,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 4,126,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 12,995,000 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 6,452,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 20,663,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 6,471,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 18,919,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 112,064,773 | shares | |
| At 2014-12-31 | 85,586,914 | shares |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 56,000 | USD | |
| At 2014-12-31 | 169,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 6,832,000 | USD | |
| At 2014-12-31 | 6,116,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 433,000 | USD | |
| At 2014-12-31 | 821,000 | USD |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 626,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 577,000 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -13,252,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -15,585,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -1,170,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -3,390,000 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 0 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -45,000 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -201,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 2,319,000 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 2,107,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -30,000 | USD | 273 |
Inspect the source
- Entity
- WINDTREE THERAPEUTICS INC /DE/ / CIK 0000946486
- Captured
- 2026-09-20T05:10:31.384Z
- SEC response SHA-256
1484517d765c2374ec787c455483b8e64ef036de472f104b5b9c5b474ad1c77e
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000946486.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))